|
Topic highlights include:
|
- Role of the JAK/STAT signaling pathway in IBD
- Available and emerging JAK inhibitors for IBD
- Thorough understanding of the JAK mechanisms of action
- Therapeutic response management/selection therapy for your IBD patient population
- Application of clinical trial and safety data to inform decisions
|
|
 |
|
Past VPP Programs
|
|
|
|
|
|
Past JAK/STAT VPP Outcomes in the Last Year
|
|
|
|
|
How does hosting work?
Hospitals, GI departments, and large gastroenterology practices that treat patients with inflammatory bowel disease should apply to host a VPP. Once your application is accepted, dedicated program staff will assist your facility in coordinating a live date for an expert faculty to present the certified education.
Who can apply to host this CME activity?
Institutions that have an interest in offering CME on incorporating novel and emerging JAK inhibitors into personalized treatment approaches for IBD are eligible to apply.
How can I apply to host this CME activity?
Click on the "Apply to Host a VPP" button to the right or contact Michelle Forcier, Senior Program Manager, at mforcier@achlcme.org. Limited spots available.
How much lead time do I need?
A minimum of six weeks is required to fully execute a VPP. Due to faculty availability, the more lead time granted, the more likely we are to confirm your preferred date.
How many CME/CE credits can I earn?
Participants are able to earn up to 1.0 AMA PRA Category 1 Credit™.
How is this program funded?
This VPP series is supported by an educational grant from Gilead Sciences, Inc.
|
|
|
|
